# Effect of iNO in Patients With Submassive and Massive PE

> **NCT04996667** · PHASE2 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Pulmonary Embolism
- Pulmonary Embolism Subacute Massive

## Interventions

- **DRUG:** inhaled nitric oxide (iNO)

## Key facts

- **NCT ID:** NCT04996667
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no sponsor support
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04996667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04996667, "Effect of iNO in Patients With Submassive and Massive PE". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04996667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*